-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RtdU0liaMzgFrXXPCkG+hKtdVHMDNQwH+I7Srd4P6RDpJyHdcK4J1wtDZkQ3ubri mSH1khhXwagZc2Itg+sHjA== 0001181431-08-014054.txt : 20080227 0001181431-08-014054.hdr.sgml : 20080227 20080227161432 ACCESSION NUMBER: 0001181431-08-014054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080225 FILED AS OF DATE: 20080227 DATE AS OF CHANGE: 20080227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VIROPHARMA INC CENTRAL INDEX KEY: 0000946840 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232789550 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 397 EAGLEVIEW BLVD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6104587300 MAIL ADDRESS: STREET 1: 397 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leone John R CENTRAL INDEX KEY: 0001301047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21699 FILM NUMBER: 08646759 BUSINESS ADDRESS: BUSINESS PHONE: 201-804-3000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: EAST RUTHERFORD STATE: NJ ZIP: 07073 4 1 rrd197233.xml X0202 4 2008-02-25 0 0000946840 VIROPHARMA INC VPHM 0001301047 Leone John R 397 EAGLEVIEW BOULEVARD EXTON PA 19341 1 0 0 0 Non-Qualified Stock Option (right-to-buy) 9.15 2008-02-25 4 A 0 10000 A 2009-02-25 2018-02-25 Common Stock 10000 10000 D The options vest in full one year from date of grant This is an option grant for which there is no purchase price. J. Peter Wolf - Attorney-In-Fact 2008-02-27 EX-24. 2 rrd175970_198724.htm POWER OF ATTORNEY rrd175970_198724.html

POWER OF ATTORNEY

            Know all by these presents, that the undersigned hereby constitutes and appoints
each of J. Peter Wolf and Vincent J. Milano, signing individually, the undersigned's true and
lawful attorney-in-fact to:
(1)	execute for and on behalf of the undersigned, in the undersigned's
capacity as an Director of ViroPharma Incorporated (the "Company"),
Forms 3, 4, and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company in accordance with Section
16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder;
(2)	do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, complete and execute any
amendment or amendments thereto, and timely file such form with the
United States Securities and Exchange Commission and any stock exchange
or similar authority; and
(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be in such form
and shall contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-fact's discretion.
            The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite, necessary or
proper to be done in the exercise of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if personally present, with full power
of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of
this power of attorney and the rights and powers herein granted.  The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934, as amended.



            This Power of Attorney shall remain in full force and effect until the undersigned
is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
            IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 18th day of February, 2008.

            				_/s/ John Leone_____________________
            				Signature


John Leone
Print Name

PHLEGAL: #1299168 v1 (R%G001!.DOC)



PHLEGAL: #1299168 v1 (R%G001!.DOC)

-----END PRIVACY-ENHANCED MESSAGE-----